IL1RAPL1
Interleukin-1 receptor accessory protein-like 1
Also known as: IL1R8, IL1RAPL, IRPL1_HUMAN, MRX10, MRX21, MRX34, OPHN4, TIGIRR-2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NZN1
- Gene
- IL1RAPL1
- Ensembl
- ENSG00000169306
- Chromosome
- X
- Canonical length
- 696 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene is a member of the interleukin 1 receptor family and is similar to the interleukin 1 accessory proteins. This protein has an N-terminal signal peptide, three extracellular immunoglobulin Ig-like domains, a transmembrane domain, an intracellular Toll/IL-1R domain, and a long C-terminal tail which interacts with multiple signalling molecules. This gene is located at a region on chromosome X that is associated with a non-syndromic form of X-linked intellectual disability. Deletions and mutations in this gene were found in patients with intellectual disability. This gene is expressed at a high level in post-natal brain structures involved in the hippocampal memory system, which suggests a specialized role in the physiological processes underlying memory and learning abilities, and plays a role in synapse formation and stabilization. [provided by RefSeq, Jul 2017]
Canonical amino-acid sequenceUniProt
696 residues, UniProt reviewed canonical sequence.
>Q9NZN1|IL1RAPL1
1 MKAPIPHLIL LYATFTQSLK VVTKRGSADG CTDWSIDIKK YQVLVGEPVR IKCALFYGYI
61 RTNYSLAQSA GLSLMWYKSS GPGDFEEPIA FDGSRMSKEE DSIWFRPTLL QDSGLYACVI
121 RNSTYCMKVS ISLTVGENDT GLCYNSKMKY FEKAELSKSK EISCRDIEDF LLPTREPEIL
181 WYKECRTKTW RPSIVFKRDT LLIREVREDD IGNYTCELKY GGFVVRRTTE LTVTAPLTDK
241 PPKLLYPMES KLTIQETQLG DSANLTCRAF FGYSGDVSPL IYWMKGEKFI EDLDENRVWE
301 SDIRILKEHL GEQEVSISLI VDSVEEGDLG NYSCYVENGN GRRHASVLLH KRELMYTVEL
361 AGGLGAILLL LVCLVTIYKC YKIEIMLFYR NHFGAEELDG DNKDYDAYLS YTKVDPDQWN
421 QETGEEERFA LEILPDMLEK HYGYKLFIPD RDLIPTGTYI EDVARCVDQS KRLIIVMTPN
481 YVVRRGWSIF ELETRLRNML VTGEIKVILI ECSELRGIMN YQEVEALKHT IKLLTVIKWH
541 GPKCNKLNSK FWKRLQYEMP FKRIEPITHE QALDVSEQGP FGELQTVSAI SMAAATSTAL
601 ATAHPDLRST FHNTYHSQMR QKHYYRSYEY DVPPTGTLPL TSIGNQHTYC NIPMTLINGQ
661 RPQTKSSREQ NPDEAHTNSA ILPLLPRETS ISSVIWLocalizationUniProt · AlphaFold · HPA
Whether an antibody against IL1RAPL1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.39
- Highest tissue expression
- 2.9 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 2.9 nTPM
- spinal cord: 1.4 nTPM
- hippocampal formation: 0.9 nTPM
- midbrain: 0.8 nTPM
- amygdala: 0.7 nTPM
- basal ganglia: 0.7 nTPM
Single-cell type
- oligodendrocytes: 7,726 nCPM
- oligodendrocyte progenitor cells: 2,678 nCPM
- brain inhibitory neurons: 2,265 nCPM
- cardiomyocytes: 1,773 nCPM
- brain excitatory neurons: 1,457 nCPM
- retinal amacrine cells: 994 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- white matter: 86 nTPM
- basal ganglia: 43 nTPM
- cerebral cortex: 38 nTPM
- thalamus: 37 nTPM
- medulla oblongata: 36 nTPM
- pons: 31 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about IL1RAPL1.
Disease | AllUniProt
Conditions IL1RAPL1 is implicated in, by any mechanism.
- Intellectual developmental disorder, X-linked 21 (XLID21) MIM:300143
Disease | GeneticClinVar
32 pathogenic / likely-pathogenic of 357 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Intellectual disability, X-linked 21
- See cases
- Intellectual disability
- Inborn genetic diseases
- IL1RAPL1-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.2
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.77
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell surface receptor signaling pathway
- negative regulation of exocytosis
- neuron differentiation
- positive regulation of dendritic spine morphogenesis
- positive regulation of synapse assembly
- presynaptic membrane assembly
- regulation of neuron projection development
- regulation of postsynapse organization
- regulation of presynapse assembly
- synaptic membrane adhesion
- trans-synaptic signaling by trans-synaptic complex
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Toll/interleukin-1 receptor homology (TIR) domain
- Immunoglobulin subtype 2
- Immunoglobulin domain subtype
- Immunoglobulin-like domain
- Immunoglobulin-like beta-sandwich domain
- Immunoglobulin-like fold
- Interleukin-1 receptor family
- Toll/interleukin-1 receptor homology (TIR) domain superfamily
- Immunoglobulin-like domain superfamily
- IL-1Ra-like, immunoglobulin domain
- Immunoglobulin domain
- TIR domain
- Immunoglobulin domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of IL1RAPL1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IL1RAPL1 as an antibody target. Whether an autoantibody or antibody against IL1RAPL1 could matter depends on whether native IL1RAPL1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IL1RAPL1 is annotated at the cell surface, where native IL1RAPL1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label IL1RAPL1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...